Jakarta, Indonesia, 22 August 2013 – Children across Indonesia are set to be protected from five major childhood diseases through the pentavalent vaccine thanks to an ambitious plan to reach children across the country’s 6,000 inhabited islands by the end of next year.
GAVI is supporting Indonesia’s plan to introduce the vaccine nationwide as quickly as possible. The country expects the vaccine to reach children nationwide by the end of 2014 - almost half the time taken for a previous national vaccine introduction.
The pentavalent vaccine will be purchased from Bio Farma, a national vaccine supplier based in Bandung, 100 miles from the capital Jakarta, meaning that Indonesian children will benefit from Indonesian innovation.
The vaccine, which contains five antigens in one shot and protects against diphtheria-tetanus-pertussis (DTP), hepatitis B and Haemophilius influenzae type b (Hib), reduces the number of separate injections required for protection and minimises the number of health centre visits required. Indonesia previously used tetravalent which does not protect against Hib.
Indonesian Minister of Health HE Nafsiah Mboi was joined by Helen Evans, deputy CEO of the GAVI Alliance, at a launch event hosted by Dr H. Ade Swara, MH, Mayor of Karawang District.
Angela Kearney and Dr Khanchit Limpakarnjanarat from GAVI Alliance partners UNICEF and WHO also took part in the ceremony and James Gilling, Head of AusAID Indonesia and Australian Ambassador for HIV/AIDS, Tuberculosis and Malaria, spoke on behalf of GAVI donors.
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?